ArticleBMC bioinformatics2025
HarmonizR: blocking and singular feature data adjustment improve runtime efficiency and data preservation.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundData adjustment is an essential tool for increasing statistical power during analysis, for example in case of complex multi-experiment data from (single-cell) RNA, proteomics and other omics data. Despite its benefits, data integration introduces internal biases-so-called batch effects. Due to the inherent presence of missing values by such methods and their additional introduction by means of data integration, renowned algorithms such as ComBat and limma are unable to perform batch effect adjustment. Recently, the HarmonizR framework was presented for these cases, which is a tool for missing value tolerant data adjustment.
resultsIn this contribution, we provide significant improvements to the HarmonizR approach. A novel blocking strategy is introduced to severely reduce runtime, while still supporting parallel architectures. Additionally, a "unique removal" strategy has been integrated into HarmonizR to maintain even more features for adjustment in datasets, showing a feature rescue of up to 103.9% for our tested datasets. In this work, we show (1) severely improved runtime for both small and large, real datasets and (2) the ability retain more features from the integrated dataset during adjustment, showing a feature rescue of up to 103.9% for our tested datasets.
conclusionThe proposed improvements tackle the previous shortcomings of the published HarmonizR version. Since HarmonizR was mainly developed for dataset integration on rare tumor entities, it did not include runtime improvements beyond parallelization, which has been addressed in this update. An additionally welcome update regarding improved feature rescue furthermore enhances the algorithms ability to quickly and robustly perform batch effect reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.